[E4] English session
Nerve / Muscular disease

[E-023] A Phase 1b/2 study of RG6206 (BMS-986089) in boys with Duchenne muscular dystrophy: 72-week update

Roxana Dreghici¹, Kathryn R. Wagner², Brenda L. Wong^3,4, Barry J. Byrne⁵, Cuixia Tian⁴, Leslie K. Jacobsen⁶, Giridhar S. Tirucherai⁶, Michael Rabbia⁷, Heidemarie Kletzl¹, Karl Yen¹, Gautam Sajeev⁸, James Signorovitch^8,9, Susan J. Ward⁹, Michelle Krishnan¹ (1.F. Hoffmann-La Roche, Basel, Switzerland, 2.The Johns Hopkins School of Medicine, Baltimore, MD, USA, 3.UMass Memorial Children’s Medical Center, Worcester, MA, US, 4.Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA, 5.University of Florida, Gainesville, FL, USA, 6.Bristol-Myers Squibb, Princeton, NJ, USA, 7.Genentech Inc, South San Francisco, CA, USA, 8.Analysis Group, Inc., Boston, MA, USA, 9.Collaborative Trajectory Analysis Project(cTAP), Cambridge, MA, USA)